H Myint1, F M Ross, J L Hall, T J Hamblin. Show Affiliations » 1. Department of Haematology, Royal Bournemouth Hospital, UK.
Abstract
Entities: Disease
Mesh: See more » AdultAntineoplastic Combined Chemotherapy Protocols/therapeutic useChromosome AberrationsChromosome DisordersChromosome InversionChromosome MappingChromosomes, Human, Pair 16Chromosomes, Human, Pair 22Chromosomes, Human, Pair 9Cytarabine/administration & dosageFatal OutcomeHumansIdarubicin/administration & dosageKaryotypingLeukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapyLeukemia, Myelogenous, Chronic, BCR-ABL Positive/geneticsLeukemia, Myelogenous, Chronic, BCR-ABL Positive/pathologyLeukemia, Myeloid, Acute/drug therapyLeukemia, Myeloid, Acute/geneticsLeukemia, Myeloid, Acute/pathologyMalePhiladelphia Chromosome
Substances: See more » CytarabineIdarubicin
Year: 1997 PMID: 9225078 DOI: 10.1016/s0145-2126(97)00070-2
Source DB: PubMed Journal: Leuk Res ISSN: 0145-2126 Impact factor: 3.156